5-HT2A receptor blockade and 5-HT2C receptor activation interact to reduce cocaine hyperlocomotion and fos protein expression in the caudate-putamen

Synapse

Volumn 66, Issue 12, 2012, Pages 989-1001

  Pockros, Lara A ^a   Pentkowski, Nathan S ^a,b   Conway, Sineadh M ^b   Ullman, Teresa E ^b   Zwick, Kimberly R ^b   Neisewander, Janet L ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Cocaine; Locomotion; M100907; MK212; Serotonin

Indexed keywords

6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; COCAINE; PROTEIN FOS; VOLINANSERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE PUTAMEN; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; HYPERLOCOMOTION; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MOTOR DYSFUNCTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CAUDATE NUCLEUS; COCAINE; FLUOROBENZENES; GENE EXPRESSION REGULATION; LOCOMOTION; MALE; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-FOS; PUTAMEN; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN 5-HT2 RECEPTOR AGONISTS; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS;

EID: 84867634892     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21592     Document Type: Article

References (97)

1. Abdallah L, Bonasera SJ, Hopf FW, O'Dell L, Giorgetti M, Jongsma M, Carra S, Pierucci M, Di Giovanni G, Esposito E, Parsons LH, Bonci A, Tecott LH. 2009. Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. J Neurosci 29: 8156-8165.
2. Agnoli L, Carli M. 2012. Dorsal-striatal 5-HTA and 5-HTC receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task. Psychopharmacology 219: 633-645.
3. Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA. 2005. Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55: 242-251.
4. Aronson SC, Black JE, McDougle CJ, Scanley BE, Jatlow P, Kosten TR, Heninger GR, Price LH. 1995. Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology (Berl) 119: 179-185.
5. Barwick VS, Jones DH, Richter JT, Hicks PB, Young KA. 2000. Subthalamic nucleus microinjections of 5-HT2 receptor antagonists suppress stereotypy in rats. Neuroreport 11: 267-270.
6. Berg KA, Harvey JA, Spampinato U, Clarke WP. 2008. Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression. Progr Brain Res 172: 287-305.
7. Beyeler A, Kadiri N, Navailles S, Boujema MB, Gonon F, Moine CL, Gross C, De Deurwaerdere P. 2010. Stimulation of serotonin2C receptors elicits abnormal oral movements by acting on pathways other than the sensorimotor one in the rat basal ganglia. Neuroscience 169: 158-170.
8. Bhattacharyya AK, Pradhan SN. 1979. Interactions between motor activity and sterotypy in cocaine-treated rats. Psychopharmacology 63: 311-312.
9. Brown EE, Finlay JM, Wong JT, Damsma G, Fibiger HC. 1991. Behavioral and neurochemical interactions between cocaine and buprenorphine: Implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Therapeut 256: 119-126.
10. Brown EE, Robertson GS, Fibiger HC. 1992. Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: Role of forebrain limbic structures. J Neurosci 12: 4112-4121.
11. Bubar MJ, Cunningham KA. 2007. Distribution of serotonin 5-HT2C receptors in the ventral tegmental area. Neuroscience 146: 286-297.
12. Bubar MJ, Cunningham KA. 2008. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Progr Brain Res 172: 319-346.
13. Bubser M, Backstrom JR, Sanders-Bush E, Roth BL, Deutch AY. 2001. Distribution of serotonin 5-HT(2A) receptors in afferents of the rat striatum. Synapse 39: 297-304.
14. Budygin EA. 2007. Dopamine uptake inhibition is positively correlated with cocaine-induced stereotyped behavior. Neurosci Lett 429: 55-58.
15. Callahan PM, Appel JB, Cunningham KA. 1991. Dopamine D1 and D2 mediation of the discriminative stimulus properties of D-amphetamine and cocaine. Psychopharmacology 103: 50-55.
16. Crawford CA, McDougall SA, Bolanos CA, Hall S, Berger SP. 1995. The effects of the kappa agonist U-50, 488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. Psychopharmacology (Berl) 120: 392-399.
17. Cussac D, Newman-Tancredi A, Duqueyroix D, Pasteau V, Millan MJ. 2002. Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: Influence of receptor reserve and relationship to agonist-directed trafficking. Mol Pharmacol 62: 578-589.
18. De Deurwaerdere P, Spampinato U. 1999. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J Neurochem 73: 1033-1042.
19. De Deurwaerdere P, Navailles S, Berg KA, Clarke WP, Spampinato U. 2004. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 24: 3235-3241.
20. De Deurwaerdere P, Le Moine C, Chesselet MF. 2010. Selective blockade of serotonin 2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia. Neurosci Lett 469: 251-255.
21. Dekeyne A, Girardon S, Millan MJ. 1999. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: A pharmacological analysis. Neuropharmacology 38: 415-423.
22. Dielenberg RA, Hunt GE, McGregor IS. 2001 "When a rat smells a cat": the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor. Neuroscience 104: 1085-1097.
23. Di Giovanni G, De Deurwaerdere P, Di Mascio M, Di Matteo V, Esposito E, Spampinato U. 1999. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: A combined in vivo electrophysiological and microdialysis study. Neuroscience 91: 587-597.
24. Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E. 2000. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors. Brain Res 865: 85-90.
25. Doherty MD, Pickel VM. 2000. Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area. Brain Res 864: 176-185.
26. Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet MF. 1997. Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 384: 233-247.
27. Feldman RS, Meyer JS, Quenzer LF. 1997. Catecholamines. Principles of neuropsychopharmacology. Sunderland, MA: Sinauer Associates. p 277-344.
28. Filip M, Bubar MJ, Cunningham KA. 2004. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: Acute and chronic pharmacological analyses. J Pharmacol Exp Therapeut 310: 1246-1254.
29. Fletcher PJ, Grottick AJ, Higgins GA. 2002. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27: 576-586.
30. Fletcher PJ, Tampakeras M, Sinyard J, Higgins GA. 2007. Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology 195: 223-234.
31. Fletcher PJ, Rizos Z, Sinyard J, Tampakeras M, Higgins GA. 2008. The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology 33: 1402-1412.
32. Fletcher PJ, Rizos Z, Noble K, Soko AD, Silenieks LB, Le AD, Higgins GA. 2012. Effects of the 5-HT(2C) receptor agonist Ro60-0175 and the 5-HT(2A) receptor antagonist M100907 on nicotine self-administration and reinstatement. Neuropharmacology 62: 2288-2298.
33. Glennon RA, Naiman NA, Pierson ME, Smith JD, Ismaiel AM, Titeler M, Lyon RA. 1989. N-(phthalimidoalkyl) derivatives of serotonergic agents: A common interaction at 5-HT1A serotonin binding sites? J Med Chem 32: 1921-1926.
34. Gobert A, Millan MJ. 1999. Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38: 315-317.
35. Gobert A, Rivet JM, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas JP, Cistarelli L, Melon C, Millan MJ. 2000. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat. Synapse 36: 205-221.
36. Gotoh K, Liu M, Benoit SC, Clegg DJ, Davidson WS, D'Alessio D, Seeley RJ, Tso P, Woods SC. 2006. Apolipoprotein A-IV interacts synergistically with melanocortins to reduce food intake. Am J Physiol Regul Integr Comp Physiol 290: R202-R207.
37. Graybiel AM, Moratalla R, Robertson HA. 1990. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 87: 6912-6916.
38. Gresch PJ, Barrett RJ, Sanders-Bush E, Smith RL. 2007. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of D-lysergic acid diethylamide. J Pharmacol Exp Therapeut 320: 662-669.
39. Grottick AJ, Fletcher PJ, Higgins GA. 2000. Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Therapeut 295: 1183-1191.
40. Grottick AJ, Corrigall WA, Higgins GA. 2001. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology 157: 292-298.
41. Halford JC, Harrold JA, Boyland EJ, Lawton CL, Blundell JE. 2007. Serotonergic drugs: Effects on appetite expression and use for the treatment of obesity. Drugs 67: 27-55.
42. Hamlin AS, Clemens KJ, McNally GP. 2008. Renewal of extinguished cocaine-seeking. Neuroscience 151: 659-670.
43. Harlan RE, Garcia MM. 1998. Drugs of abuse and immediate-early genes in the forebrain. Mol Neurobiol 16: 221-267.
44. Herrera DG, Robertson HA. 1996. Activation of c-fos in the brain. Prog Neurobiol 50: 83-107.
45. Higgins GA, Enderlin M, Haman M, Fletcher PJ. 2003. The 5-HT2A receptor antagonist M100, 907 attenuates motor and "impulsive-type" behaviors produced by NMDA receptor antagonism. Psychopharmacology 170: 309-319.
46. 2C receptors. Eur J Pharmacol 480: 151-162.
47. Hitchcock JM, Lister S, Fischer TR, Wettstein JG. 1997. Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: Effects of MDL 100, 907, clozapine, risperidone and haloperidol. Behav Brain Res 88: 43-49.
48. Hotsenpiller G, Horak BT, Wolf ME. 2002. Dissociation of conditioned locomotion and Fos induction in response to stimuli formerly paired with cocaine. Behav Neurosci 116: 634-645.
49. Hoyer D, Hannon JP, Martin GR. 2002. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71: 533-554.
50. Hurd YL, Ungerstedt U. 1989. Cocaine: An in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse 3: 48-54.
51. Hurd YL, Weiss F, Koob G, Ungerstedt U. 1990. The influence of cocaine self-administration on in vivo dopamine and acetylcholine neurotransmission in rat caudate-putamen. Neurosci Lett 109: 227-233.
52. Ichikawa J, Meltzer HY. 1995. DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Res 698: 204-208.
53. Invernizzi RW, Pierucci M, Calcagno E, Di Giovanni G, Di Matteo V, Benigno A, Esposito E. 2007. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: A combined in vivo electrophysiological and neurochemical study. Neuroscience 144: 1523-1535.
54. Jackson DM, Westlind-Danielsson A. 1994. Dopamine receptors: Molecular biology, biochemistry and behavioral aspects. Pharmacol Ther 64: 291-370.
55. Kehne JH, Baron BM, Carr AA, Chaney SF, Elands J, Feldman DJ, Frank RA, van Giersbergen PL, McCloskey TC, Johnson MP, McCarty DR, Poirot M, Senyah Y, Siegel BW, Widmaier C. 1996. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100, 907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Therapeut 277: 968-981.
56. Kufahl PR, Pentkowski NS, Heintzelman K, Neisewander JL. 2009a. Cocaine-induced Fos expression is detectable in the frontal cortex and striatum of rats under isoflurane but not alpha-chloralose anesthesia: Implications for FMRI. J Neurosci Methods 181: 241-248.
57. Kufahl PR, Zavala AR, Singh A, Thiel KJ, Dickey ED, Joyce JN, Neisewander JL. 2009b. c-Fos expression associated with reinstatement of cocaine-seeking behavior by response-contingent conditioned cues. Synapse 63: 823-835.
58. Levin ED, Slade S, Johnson M, Petro A, Horton K, Williams P, Rezvani AH, Rose JE. 2008. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. Eur J Pharmacol 600: 93-97.
59. Lucas G, Spampinato U. 2000. Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. J Neurochem 74: 693-701.
60. McCreary AC, Filip M, Cunningham KA. 2003. Discriminative stimulus properties of (+/-)-fenfluramine: The role of 5-HT2 receptor subtypes. Behav Neurosci 117: 212-221.
61. 2C receptors. J Neurosci 21: 7781-7787.
62. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: From structure to function. Physiol Rev 78: 189-225.
63. Naylor RJ, Olley JE. 1972. Modification of the behavioral changes induced by haloperidol in the ray by lesions in the caudate nucleus, the caudate-putamen and globus pallidus. Neuropharmacology 11: 81-89.
64. Neisewander JL, Acosta JI. 2007. Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol 18: 791-800.
65. Neisewander JL, Baker DA, Fuchs RA, Tran-Nguyen LT, Palmer A, Marshall JF. 2000. Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci 20: 798-805.
66. Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA. 2009. Blockade of the serotonin 5-ht2a receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci 123: 382-396.
67. NIH. 2010. Available at: www.clinicaltrials.gov. National Institute of Health.
68. Ninan I, Kulkarni SK. 1998. 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion. Eur J Pharmacol 358: 111-116.
69. O'Dell LE, Khroyan TV, Neisewander JL. 1996. Dose-dependent characterization of the rewarding and stimulant properties of cocaine following intraperitoneal and intravenous administration in rats. Psychopharmacology 123: 144-153.
70. Paxinos GW, C. 2007. The rat brain in stereotaxic coordinates Amsterdam; Boston: Academic Press/Elsevier.
71. Pentkowski NS, Duke FD, Weber SM, Pockros LA, Teer AP, Hamilton EC, Thiel KJ, Neisewander JL. 2010. Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior. Neuropsychopharmacology 35: 2037-2048.
72. Pockros LA, Pentkowski NS, Weber SM, Neisewander JL. 2011. Stimulation of serotonin 2C receptors in the mPFC attenuates cocaine-induced hyperlocomotion and alters Fos expression in brain regions containing dopamine neurons. Washington, DC: Society for Neuroscience.
73. Pompeiano M, Palacios JM, Mengod G. 1994. Distribution of the serotonin 5-HT2 receptor family mRNAs: Comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 23: 163-178.
74. Porras G, Di Matteo V, Fracasso C, Lucas G, De Deurwaerdere P, Caccia S, Esposito E, Spampinato U. 2002. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26: 311-324.
75. 2C receptors in CHO-K1 cells. Br J Pharmacol 128: 13-20.
76. Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN. 2001. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92: 179-212.
77. Robertson HA, Paul ML, Moratalla R, Graybiel AM. 1991. Expression of the immediate early gene c-fos in basal ganglia: Induction by dopaminergic drugs. Can J Neurol Sci 18: 380-383.
78. Rocha BA, Goulding EH, O'Dell LE, Mead AN, Coufal NG, Parsons LH, Tecott LH. 2002. Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neurosci 22: 10039-10045.
79. Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL. 1992. 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: Studies with MDL 100, 907 and the amphetamine analogue, 3, 4-methylenedioxymethamphetamine. Eur J Pharmacol 223: 65-74.
80. Schmidt CJ, Sullivan CK, Fadayel GM. 1994. Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3, 4-methylenedioxymethamphetamine. J Neurochem 62: 1382-1389.
81. Steed E, Jones CA, McCreary AC. 2011. Serotonergic involvement in methamphetamine-induced locomotor activity: A detailed pharmacological study. Behav Brain Res 220: 9-19.
82. Stiedl O, Misane I, Koch M, Pattij T, Meyer M, Ogren SO. 2007. Activation of the brain 5-HT2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice. Neuropharmacology 52: 949-957.
83. Szucs RP, Frankel PS, McMahon LR, Cunningham KA. 2005. Relationship of cocaine-induced c-Fos expression to behaviors and the role of serotonin 5-HT2A receptors in cocaine-induced c-Fos expression. Behav Neuroscience 119: 1173-1183.
84. Talvik-Lotfi M, Nyberg S, Nordstrom AL, Ito H, Halldin C, Brunner F, Farde L. 2000. High 5HT2A receptor occupancy in M100907-treated schizophrenic patients. Psychopharmacology 148: 400-403.
85. Thiel KJ, Sanabria F, Neisewander JL. 2009. Synergistic interaction between nicotine and social rewards in adolescent male rats. Psychopharmacology (Berl) 204: 391-402.
86. Torres G, Rivier C. 1994. Induction of c-fos in rat brain by acute cocaine and fenfluramine exposure: A comparison study. Brain Res 647: 1-9.
87. Vickers SP, Easton N, Malcolm CS, Allen NH, Porter RH, Bickerdike MJ, Kennett GA. 2001. Modulation of 5-HT(2A) receptor-mediated head-twitch behavior in the rat by 5-HT(2C) receptor agonists. Pharmacol Biochem Behav 69: 643-652.
88. Washton AM. 1988. Preventing relapse to cocaine. J Clin Psychiatr 49( Suppl): 34-38.
89. Wettstein JG, Host M, Hitchcock JM. 1999. Selectivity of action of typical and atypical anti-psychotic drugs as antagonists of the behavioral effects of 1-[2, 5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI). Prog Neuropsychopharmacol Biol Psychiatr 23: 533-544.
90. White IM, Doubles L, Rebec GV. 1998. Cocaine-induced activation of striatal neurons during focused stereotypy in rats. Brain Res 810: 146-152.
91. Whitten L. 2007. Serotonin system may have potential as target for cocaine medications. NIDA Notes. www.drugabuse.gov.
92. Willins DL, Meltzer HY. 1998. Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. Brain Res 781: 291-299.
93. Young ST, Porrino LJ, Iadarola MJ. 1991. Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci USA 88: 1291-1295.
94. Zahm DS, Becker ML, Freiman AJ, Strauch S, Degarmo B, Geisler S, Meredith GE, Marinelli M. 2010. Fos after single and repeated self-administration of cocaine and saline in the rat: Emphasis on the basal forebrain and recalibration of expression. Neuropsychopharmacology 35: 445-463.
95. Zaniewska M, McCreary AC, Przegalinski E, Filip M. 2007. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats. Eur J Pharmacol 571: 156-165.
96. Zavala AR, Biswas S, Harlan RE, Neisewander JL. 2007. Fos and glutamate AMPA receptor subunit coexpression associated with cue-elicited cocaine-seeking behavior in abstinent rats. Neuroscience 145: 438-452.
97. Zimmerberg B, Glick SD. 1974. Rotation and stereotypy during electrical stimulation of the caudate nucleus. Res Commun Chem Pathol Pharmacol 8: 195.